Q4 & FY22 Highlights slide image

Q4 & FY22 Highlights

Consistent investments in R&D DSIR recognized In House R&D unit with an experienced team of research scientists and doctors SEIENTIFIC & TRIAL RESEARCH GOVT. OF IN INDUST DSIR RECOGNIZED RECOGNITION FOR IN-HOUSE R&D 07 R&D Collaboration जवाहरलाल नेहरू विश्वविद्यालय Jawaharlal Nehru University Jawaharlal Nehru University for development of diagnostics kit for detection of mycobacterium tuberculosis and mycoabacterial species with marquee institutions CSIR-Institute of Genomics and Integrative Biology for acquisition of know-how for 27 diagnostic assays IG B INSTITUTE OF GENOMICS & INTEGRATIVE BIOLOGY Genomics Knowledge Partner Sanger Sequencing, Single Variant Sickle Cell Trio Prenatal Mutation Detection Successful commercialization of tests Leigh Syndrome Mitochondrial Mutation Detection Spino-Bulbar- Muscular Atrophy Episodic Ataxia Type 2 38 Dr Lal PathLabs
View entire presentation